Literature DB >> 26315603

Increased density of DISC1-immunoreactive oligodendroglial cells in fronto-parietal white matter of patients with paranoid schizophrenia.

Hans-Gert Bernstein1, Esther Jauch2, Henrik Dobrowolny2, Christian Mawrin3, Johann Steiner2, Bernhard Bogerts2.   

Abstract

Profound white matter abnormalities have repeatedly been described in schizophrenia, which involve the altered expression of numerous oligodendrocyte-associated genes. Transcripts of the disrupted-in-schizophrenia 1 (DISC1) gene, a key susceptibility factor in schizophrenia, have recently been shown to be expressed by oligodendroglial cells and to negatively regulate oligodendrocyte differentiation and maturation. To learn more about the putative role(s) of oligodendroglia-associated DISC1 in schizophrenia, we analyzed the density of DISC1-immunoreactive oligodendrocytes in the fronto-parietal white matter in postmortem brains of patients with schizophrenia. Compared with controls (N = 12) and cases with undifferentiated/residual schizophrenia (N = 6), there was a significantly increased density of DISC1-expressing glial cells in paranoid schizophrenia (N = 12), which unlikely resulted from neuroleptic treatment. Pathophysiologically, over-expression of DISC1 protein(s) in white matter oligodendrocytes might add to the reduced levels of two myelin markers, 2',3'-cyclic-nucleotide 3'-phosphodiesterase and myelin basic protein in schizophrenia. Moreover, it might significantly contribute to cell cycle abnormalities as well as to deficits in oligodendroglial cell differentiation and maturation found in schizophrenia.

Entities:  

Keywords:  Disrupted-in-schizophrenia 1 (DISC1); Immunohistochemistry; Paranoid schizophrenia; Schizophrenia; White matter oligodendroglia

Mesh:

Substances:

Year:  2015        PMID: 26315603     DOI: 10.1007/s00406-015-0640-y

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  66 in total

1.  Expression of mutant human DISC1 in mice supports abnormalities in differentiation of oligodendrocytes.

Authors:  Pavel Katsel; Weilun Tan; Bagrat Abazyan; Kenneth L Davis; Christopher Ross; Mikhail V Pletnikov; Vahram Haroutunian
Journal:  Schizophr Res       Date:  2011-05-24       Impact factor: 4.939

2.  Association analysis of the DISC1 gene with schizophrenia in the Japanese population and DISC1 immunoreactivity in the postmortem brain.

Authors:  Woraphat Ratta-Apha; Akitoyo Hishimoto; Kentaro Mouri; Kyoichi Shiroiwa; Toru Sasada; Masakuni Yoshida; Irwan Supriyanto; Yasuhiro Ueno; Migiwa Asano; Osamu Shirakawa; Hideru Togashi; Yoshimi Takai; Ichiro Sora
Journal:  Neurosci Res       Date:  2013-09-04       Impact factor: 3.304

3.  DISC1 is associated with cortical thickness and neural efficiency.

Authors:  Stefan Brauns; Randy L Gollub; Joshua L Roffman; Anastasia Yendiki; Beng-Choon Ho; Thomas H Wassink; Andreas Heinz; Stefan Ehrlich
Journal:  Neuroimage       Date:  2011-05-27       Impact factor: 6.556

4.  Specific glial functions contribute to schizophrenia susceptibility.

Authors:  Andrea Goudriaan; Christiaan de Leeuw; Stephan Ripke; Christina M Hultman; Pamela Sklar; Patrick F Sullivan; August B Smit; Danielle Posthuma; Mark H G Verheijen
Journal:  Schizophr Bull       Date:  2013-08-16       Impact factor: 9.306

5.  Immunohistochemical evidence for impaired neuregulin-1 signaling in the prefrontal cortex in schizophrenia and in unipolar depression.

Authors:  Iris Bertram; Hans-Gert Bernstein; Uwe Lendeckel; Alicja Bukowska; Henrik Dobrowolny; Gerburg Keilhoff; Dimitrios Kanakis; Christian Mawrin; Hendrik Bielau; Peter Falkai; Bernhard Bogerts
Journal:  Ann N Y Acad Sci       Date:  2007-01       Impact factor: 5.691

6.  Gene expression analysis in blood of ultra-high risk subjects compared to first-episode of psychosis patients and controls.

Authors:  Marcos Leite Santoro; Ary Gadelha; Vanessa K Ota; Graccielle R Cunha; Elson Asevedo; Cristiano S Noto; Leticia M Spindola; Pedro M Pan; Fernanda Talarico; Rodrigo B Mansur; Patricia N Silva; Elisa Brietzke; Quirino Cordeiro; Rodrigo A Bressan; Sintia Iole Belangero
Journal:  World J Biol Psychiatry       Date:  2015-06-18       Impact factor: 4.132

7.  Structural disconnectivity in schizophrenia: a diffusion tensor magnetic resonance imaging study.

Authors:  J Burns; D Job; M E Bastin; H Whalley; T Macgillivray; E C Johnstone; S M Lawrie
Journal:  Br J Psychiatry       Date:  2003-05       Impact factor: 9.319

Review 8.  Human brain imaging studies of DISC1 in schizophrenia, bipolar disorder and depression: a systematic review.

Authors:  Barbara J Duff; Karine A N Macritchie; Thomas W J Moorhead; Stephen M Lawrie; Douglas H R Blackwood
Journal:  Schizophr Res       Date:  2013-04-16       Impact factor: 4.939

9.  Abnormal indices of cell cycle activity in schizophrenia and their potential association with oligodendrocytes.

Authors:  Pavel Katsel; Kenneth L Davis; Celeste Li; Weilun Tan; Elizabeth Greenstein; Lisa B Kleiner Hoffman; Vahram Haroutunian
Journal:  Neuropsychopharmacology       Date:  2008-03-05       Impact factor: 7.853

10.  Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium.

Authors:  Natalya A Uranova; Victor M Vostrikov; Diana D Orlovskaya; Valentina I Rachmanova
Journal:  Schizophr Res       Date:  2004-04-01       Impact factor: 4.939

View more
  3 in total

1.  Reduced Density of DISC1 Expressing Astrocytes in the Dentate Gyrus but not in the Subventricular Zone in Schizophrenia.

Authors:  Hans-Gert Bernstein; Henrik Dobrowolny; Gerburg Keilhoff; Bernhard Bogerts; Johann Steiner
Journal:  Neuropsychopharmacology       Date:  2018-02       Impact factor: 7.853

2.  Markers of copper transport in the cingulum bundle in schizophrenia.

Authors:  Kirsten E Schoonover; Rosalinda C Roberts
Journal:  Schizophr Res       Date:  2021-01-09       Impact factor: 4.939

Review 3.  Novel Treatment Strategies Targeting Myelin and Oligodendrocyte Dysfunction in Schizophrenia.

Authors:  Danielle Gouvêa-Junqueira; Ana Caroline Brambilla Falvella; André Saraiva Leão Marcelo Antunes; Gabriela Seabra; Caroline Brandão-Teles; Daniel Martins-de-Souza; Fernanda Crunfli
Journal:  Front Psychiatry       Date:  2020-04-30       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.